Differential methylation of tissue- and cancer-specific CpG island shores distinguishes human induced pluripotent stem cells, embryonic stem cells and fibroblasts
By A. Doi, In-Hyun Park, Bo Wen, Peter N. Murakami, Martin J. Aryee, Rafael A. Irizarry, Brian R. Herb, Christine Ladd-Acosta, Junsung Rho, Sabine Loewer and 4 more. Nature Genetics, 2009
1,195 citations recorded by the source corpus.
Induced pluripotent stem (iPS) cells are derived by epigenetic reprogramming, but their DNA methylation patterns have not yet been analyzed on a genome-wide scale. Here, we find substantial hypermethylation and hypomethylation of cytosine-phosphate-guanine (CpG) island shores in nine human iPS cell lines as compared to their parental fibroblasts. The differentially methylated regions (DMRs) in the reprogrammed cells (denoted R-DMRs) were significantly enriched in tissue-specific (T-DMRs; 2.6-fold, P < 10−4) and cancer-specific DMRs (C-DMRs; 3.6-fold, P < 10−4). Notably, even though the iPS cells are derived from fibroblasts, their R-DMRs can distinguish between normal brain, liver and spleen cells and between colon cancer and normal colon cells. Thus, many DMRs are broadly involved in tissue differentiation, epigenetic reprogramming and cancer. We observed colocalization of hypomethylated R-DMRs with hypermethylated C-DMRs and bivalent chromatin marks, and colocalization of hypermethylated R-DMRs with hypomethylated C-DMRs and the absence of bivalent marks, suggesting two mechanisms for epigenetic reprogramming in iPS cells and cancer.
Subfields: Molecular Biology
View Paper: https://www.semanticscholar.org/paper/8088aac5d699457be3fca6ac7b02acfe5e2a3df2
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Molecular Biology
- Christoph Bock
- Manel Esteller
- Peter A. Jones
- S. Baylin
- K. Hochedlinger
- M. Stadtfeld
- Anna Portela
- Holger Heyn
Citations in the corpus
- A decade of exploring the cancer epigenome — biological and translational implications (2011, background): “DNA methylation patterns for conserved gene sequences several kilobases upstream or downstream of promoter CpG islands, and termed shores, are tightly linked with the tissue of origi”
- Increased methylation variation in epigenetic domains across cancer types (2011, positive): “Furthermore, cDMRs are highly enriched among regions differentially methylated during stem cell reprogramming of induced pluripotent stem (iPS) cells 5 .”
- Reference Maps of Human ES and iPS Cell Variation Enable High-Throughput Characterization of Pluripotent Cell Lines (2011, positive): “To quantitatively address this issue, we reframed them as a classification problem: Can we use DNA methylation and gene expression profiles to accurately predict whether a specific cell line is an ES or iPS cell line? Several gene signatures of differences between human ES and iPS cell lines have be”
- Energy Metabolism in Human Pluripotent Stem Cells and Their Differentiated Counterparts (2011, background): “differing from both ESCs and differentiated cells [6] , suggesting both the occurrence of abnormal methylation during reprogram-”
- Induced pluripotency: history, mechanisms, and applications. (2010, background): “At the 2252 GENES & DEVELOPMENT molecular level, gene-specific and global differences in DNA methylation (Deng et al. 2009; Doi et al. 2009; Pick et al. 2009) and in the expression of mRNAs and miRNAs (Chin et al. 2009; Wilson et al. 2009) have been reported between both mouse and human ESCs and…”
- Distinct DNA methylomes of newborns and centenarians (2012, background): “CpG sites in CpG island “shores,” extensively studied regions of comparatively low CpG density within 2 kb of CpG islands (15, 18, 19), also mostly had a more unmethylated status in the Y103 sample (Wilcoxontest, P < 2.”
- De novo identification of differentially methylated regions in the human genome (2015, background): “Background DNA methylation is widely regarded as the most stable epigenetic mark and, for explaining patterns of gene expression, cell differentiation and phenotype, one of the most informative [1-3].”
- Epigenetic modifications and human disease (2010, background): “Most of the tissue-specific DNA methylation seems to occur not at CpG islands but at CpG island shore”
- Epigenetics and Colorectal Cancer (2011, background): “The methylation of these CpG island shores tends to be tissue specific, and has been shown to be altered in CRC”
- Cancer epigenetics reaches mainstream oncology (2011, background): “Recent findings also suggest that extensive DNA methylation changes caused by differentiation take place at CpG island 'shores', regions of comparatively low CpG density close to CpG island”
- methylKit: a comprehensive R package for the analysis of genome-wide DNA methylation profiles (2012, background): “Differential methylation patterns have been previously described in malignancies [27-29] and can be used to differentiate cancer and normal cells [30].”
- DNA methylome analysis using short bisulfite sequencing data (2012, background): “These patterns are sometimes perturbed in important human diseases, such as imprinting disorders and cance”
- DNA methylation arrays as surrogate measures of cell mixture distribution (2012, background): “and results, and additional figures and result tables [43-52].”